Autologous mesenchymal stem cells from adipose tissue.
CMM/EM/2008
Phase 2 other completed
Quick answer
Autologous mesenchymal stem cells from adipose tissue. for Autoimmune Diseases is a Phase 2 program (other) at Design Therapeutics with 1 ClinicalTrials.gov record(s).
Program details
- Company
- Design Therapeutics
- Indication
- Autoimmune Diseases
- Phase
- Phase 2
- Modality
- other
- Status
- completed